Answers are grounded in this paper and cite their sources.
Case report reveals BRCA reversion mutations in triple-negative breast cancer, suggesting new resistance mechanisms.
INTRODUCTION: BRCA reversion mutations are known mechanisms of acquired resistance to poly (ADP-ribose) polymerase inhibitors (PARPis) and platinum agents. However, their clinical emergence without such therapies is rarely reported.
No takes yet. Share an insight, caveat, or question.
Hikino et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: